Global Antidepressant Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 2.7% during forecast period.

Global Antidepressant Market Overview:

Antidepressants are prescription drugs that are used to treat major depressive illness, anxiety disorders, chronic pain, and addictions. Dry mouth, weight gain, dizziness, migraines, sexual dysfunction and emotional blunting are all common antidepressant side effects.
Global Antidepressant Market Dynamics:

Rising cases of depression is one of the major factors driving the market growth.

Globally, increased cases of mental health issues are a major driver of the antidepressant drug industry's growth, as many customers rely on these prescriptions to treat depression, anxiety, and other mental illnesses. According to the World Health Organization, around 264 million individuals of all ages will be depressed by 2020. As a result, increased incidences of mental health illnesses are likely to propel the antidepressant industry forward. The rise in the senior population, the rise in the prevalence of depression, and the development of novel strategies for developing medications with fewer side effects are all driving the industry forward. Furthermore, rising public awareness of the disease and an increase in the number of people suffering from stress could propel the antidepressant drug industry forward. Ketamine, an anesthetic that has made waves for its surprising antidepressant effect, was approved by the Food and Drug Administration (FDA) in 2018. Because esketamine medication may be beneficial to individuals with treatment-resistant depression (those who have not responded to traditional therapies), the FDA has accelerated the approval procedure to make it more readily available.

However, the market is projected to be hampered by the drug's poor efficacy and safety profiles, preference for non-pharmacological therapy, and a rise in the number of antidepressant patent expirations, resulting in a weak pipeline. Lexapro (escitalopram) and Celexa (citalopram) are antidepressants that are both used to treat depression. Lexapro also helps with anxiety. Nausea, insomnia, sweating, dry mouth, and sleepiness are some of the side effects that Lexapro and Celexa might induce. In 2018, the drugs' labels included a black box warning about an increased risk of suicide. As a result, the antidepressant market's growth is projected to be constrained by side effects and patent expiration.

The report has profiled fifteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing RD activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.
Global Antidepressant Market Segment Analysis:

The Global Antidepressant Market is segmented on the basis of Product and Depressive Disorder.

Based on Product, the Selective Serotonin Reuptake Inhibitor (SSRI) segment is expected to hold a dominant market share throughout the forecast period due to the significant quantity of these medications present. The most widely used antidepressants are selective serotonin reuptake inhibitors (SSRIs). They're quite effective and have fewer negative effects than other antidepressants. SSRIs work by preventing serotonin from being reabsorbed or reuptaken in the brain, which helps to reduce depression symptoms.

Global Antidepressant Market

To know about the Research Methodology :- Request Free Sample Report

Based on Depressive Disorder, the Major Depressive Disorder segment is expected to account for dominant market share during the forecast period. The biological, psychological, and social sources of sadness are all possible causes of severe depressive disorder. Family history, substantial life changes, particular medications, chronic health conditions, and substance abuse are all key risk factors. According to the National Institute of Mental Health, 17.3 million adults in the United States experienced at least one major depressive episode in 2017. This figure represents 7.1% of all adults in the United States, and it is more common in women than in males. The average 12-month prevalence was 5.2%, with a lifetime prevalence of 11.32 %. As a result, over the projection period, the high frequency of major depressive illness is expected to drive up the demand for antidepressants. Selective serotonin reuptake inhibitors (SSRIs) are most widely used to treat serious depression, however, there are certain therapies that can help to normalise depression-related brain abnormalities. As a result of the growing patient pool and new product introductions, the market is likely to rise rapidly throughout the forecast period.
Global Antidepressant Market Regional Insights:

Global Antidepressant Market 1
North America is the dominant region in the global market.

One of the primary drivers projected to fuel the overall growth of the antidepressant market in North America, notably in the United States, throughout the forecast period is the rising prevalence of depression. Furthermore, the geriatric population in the United States are growing, which would provide additional chances for market players in the region. During the COVID-19 epidemic in the United States, the prevalence of depression increased. According to a study published in JAMA Network Open 2020, the prevalence of depression symptoms in the United States was more than three times greater during COVID-19 than before the pandemic. This was primarily due to increasing stress levels as a result of job loss and social isolation. As a result of the aforementioned considerations, COVID-19 is predicted to boost the antidepressant market in the United States during the pandemic. Furthermore, the studied market is driven by an increase in FDA approvals and pipeline goods by significant companies focused on the region.

The report also helps in understanding Global Antidepressant Market dynamics, structure by analyzing the market segments and project the Global Antidepressant Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Antidepressant Market make the report investor’s guide.

FOR MORE INFO VISIT US;

https://www.maximizemarketresearch.com/market-report/global-antidepressant-market/109273/

Global Antidepressant Market Scope: Inquire before buying

Global Antidepressant Market 2
Global Antidepressant Market, By Region:

• North America
• Europe
• South America
• MEA
• APAC
Global Antidepressant Market, Key players:

• AstraZeneca plc
• Eli Lilly and Company
• Forest Laboratories
• GlaxoSmithKline plc
• H. Lundbeck A/S
• Johnson Johnson
• Merck Co., Inc.
• Pfizer, Inc.
• Sanofi S.A.
• Allergan PLC
• Sun Pharmaceuticals Pvt Ltd.
• Alkermes Plc
• Bristol Myers Squibb Co
• Teva Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Co. Ltd.

For More Information Visit @:
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors